在循环性心肌病症中失调的处理
Sang Youn Hwang1,2, Hongqun Liu1, Samuel S Lee1
1Liver Unit, University of Calgary Cumming School of Medicine, Calgary, AB T2N 4N1, Canada.
Biomedicines
|July 29, 2023
概括
循环性心肌病症会损害心脏功能,原因是心肌细胞对的处理发生了改变. 通道和肉质网膜储存的缺陷导致这些患者的收缩性降低.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 肝硬化心肌病症的特点是肝硬化患者的心脏缩和放缩功能受损.
- 潜在的机制,特别是涉及心肌细胞处理的机制,尚未完全理解.
研究的目的:
- 审查处理系统及其在肝硬化心肌病性心脏功能障碍中的作用.
- 阐明导致肝硬化心肌病的机制.
主要方法:
- 对心肌细胞中处理现有文献的综述.
- 对过渡体,L型通道和氨酸受体 (RyRs) 在肝硬化心肌病中的分析.
主要成果:
- 减少L型通道和减少流在肝硬化心肌细胞中.
- 在肝硬化心肌细胞中,有证据表明从质网膜 (SR) 泄漏.
- 赖诺丁受体 (RyRs) 的不稳定可能导致泄漏和收缩能力降低.
结论:
- 心脏处理系统的多种缺陷有助于肝性心肌病变的发病.
- 了解这些与相关的机制对于开发治疗策略至关重要.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy I: Introduction and Classification
15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Feedback Regulation of Calcium Concentration
3.4K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.4K
Mechanism of Cardiac Arrhythmias
957
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
957


